Suppr超能文献

海湾合作委员会国家以患者为中心的真实世界证据的前景:行动呼吁。

Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action.

作者信息

Farghaly Mohamed Nasr Mahmoud Hassan, Al Ghaithi Ibrahim Sulaiman Mas'oud, Mahamid Wael Abdel Rahman, Adlan Abdallah, AlGhamdi Saleh Mohammed, Al Shammari Thamir M, Alqahtani Nasser Mohammed, Al Ghnam Suliman A, Ibrahim Marie Sleiman Awad, Al Mudaiheem Hajer, Chouikrat Mohamed Zahir, Aktham Yahia, El Bagoury Marwan Essam, Gowda Arun Jayarame, Al Moaikel Khalid, Abdallah Nancy Syed Awad

机构信息

Dubai Medical College, Dubai, United Arab Emirates.

DHIC, Dubai, United Arab Emirates.

出版信息

Drugs Real World Outcomes. 2023 Mar;10(1):1-9. doi: 10.1007/s40801-022-00336-0. Epub 2022 Nov 17.

Abstract

Presently, Gulf Cooperation Council countries are lagging in the generation of real-world data and use of real-world evidence for patient-centered care compared with the global average. In a collaborative effort, experts from multiple domains of the healthcare environment from the Gulf Cooperation Council countries came together to present their views and recommended key action points for the generation of robust real-world data and leveraging real-world evidence in the countries. The opinions of the experts are presented, along with existing barriers to the effective generation of real-world evidence in the countries. The Gulf Cooperation Council countries are undergoing transformative changes paving the way for improved healthcare measures; however, the challenges in generating reliable, robust, accessible, and secure real-world evidence are persistent. Hence, ongoing public-private engagements, as well as collaborations between regulators, policymakers, healthcare professionals, insurance and pharmaceutical companies, and patients, are warranted. A few notable examples of real-world evidence studies highlighting the benefits of real-world evidence for gaining valuable insights into patient-centric decision making are also discussed. The actionable steps identified for successful real-world evidence generation would provide long-term, real-world evidence-based patient-centric benefits for the countries.

摘要

目前,与全球平均水平相比,海湾合作委员会国家在生成真实世界数据以及将真实世界证据用于以患者为中心的医疗方面滞后。海湾合作委员会国家医疗环境多个领域的专家共同努力,汇聚一堂发表意见,并就该国生成可靠的真实世界数据和利用真实世界证据提出关键行动要点。文中呈现了专家意见以及该国有效生成真实世界证据存在的障碍。海湾合作委员会国家正在经历变革性变化,为改善医疗措施铺平道路;然而,生成可靠、有力、可获取且安全的真实世界证据方面的挑战依然存在。因此,持续的公私合作以及监管机构、政策制定者、医疗专业人员、保险公司、制药公司和患者之间的协作是必要的。文中还讨论了一些突出真实世界证据对以患者为中心的决策获得宝贵见解益处的真实世界证据研究的显著例子。为成功生成真实世界证据确定的可行动步骤将为这些国家带来长期的、基于真实世界证据的以患者为中心的益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf55/9944129/ff46b0ef507a/40801_2022_336_Fig1_HTML.jpg

相似文献

1
Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action.
Drugs Real World Outcomes. 2023 Mar;10(1):1-9. doi: 10.1007/s40801-022-00336-0. Epub 2022 Nov 17.
2
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative review.
Mult Scler J Exp Transl Clin. 2022 Mar 9;8(1):20552173221077185. doi: 10.1177/20552173221077185. eCollection 2022 Jan-Mar.
4
Unlocking the eHealth professionals' career pathways: A case of Gulf Cooperation Council countries.
Int J Med Inform. 2023 Feb;170:104914. doi: 10.1016/j.ijmedinf.2022.104914. Epub 2022 Nov 11.
6
Fighting trafficking of falsified and substandard medicinal products in Russia.
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.
7
Driving and diabetes mellitus in the Gulf Cooperation Council countries: Call for action.
Diabetes Res Clin Pract. 2015 Oct;110(1):91-94. doi: 10.1016/j.diabres.2015.08.002. Epub 2015 Aug 22.
8
Association of infections with multiple sclerosis in Gulf Cooperation Council countries: a review.
J Int Med Res. 2020 Apr;48(4):300060519884151. doi: 10.1177/0300060519884151. Epub 2019 Dec 27.
9
Patient Centricity and Pharmaceutical Companies: Is It Feasible?
Ther Innov Regul Sci. 2017 Jul;51(4):460-467. doi: 10.1177/2168479017696268. Epub 2017 Mar 28.

引用本文的文献

1
Patterns of claims and determinants of claim rejections in Kuwait's National Health Insurance for Retirees (AFYA): a comprehensive analysis.
Front Public Health. 2025 Jul 22;13:1606980. doi: 10.3389/fpubh.2025.1606980. eCollection 2025.

本文引用的文献

1
Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan.
Drugs Real World Outcomes. 2021 Dec;8(4):459-480. doi: 10.1007/s40801-021-00266-3. Epub 2021 Jun 19.
2
Use of real-world evidence for oncology clinical decision making in emerging economies.
Future Oncol. 2021 Aug;17(22):2951-2960. doi: 10.2217/fon-2021-0425. Epub 2021 May 28.
4
Benefits and limitations of real-world evidence: lessons from mutation-positive non-small-cell lung cancer.
Future Oncol. 2021 Mar;17(8):965-977. doi: 10.2217/fon-2020-0951. Epub 2020 Nov 26.
5
Bridging the Gap Between RCTs and RWE Through Endpoint Selection.
Ther Innov Regul Sci. 2021 Jan;55(1):90-96. doi: 10.1007/s43441-020-00193-5. Epub 2020 Jul 6.
6
Real-world data in Saudi Arabia: Current situation and challenges for regulatory decision-making.
Pharmacoepidemiol Drug Saf. 2020 Oct;29(10):1303-1306. doi: 10.1002/pds.5025. Epub 2020 May 27.
7
Privacy, confidentiality, security and patient safety concerns about electronic health records.
Int Nurs Rev. 2020 Jun;67(2):218-230. doi: 10.1111/inr.12585. Epub 2020 Apr 21.
8
Role of real-world evidence in informing cancer care: lessons from colorectal cancer.
Curr Oncol. 2019 Nov;26(Suppl 1):S53-S56. doi: 10.3747/co.26.5625. Epub 2019 Nov 1.
10
The Contribution of Cancer Surveillance Toward Real World Evidence in Oncology.
Semin Radiat Oncol. 2019 Oct;29(4):318-322. doi: 10.1016/j.semradonc.2019.05.004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验